Department of Chemistry, Grand Valley State University, Allendale, Michigan 49401, USA.
Biochemistry. 2009 Dec 22;48(50):11840-7. doi: 10.1021/bi901690r.
The clinical efficacy of carbapenem antibiotics depends on their resistance to the hydrolytic action of beta-lactamase enzymes. The structure of the class D beta-lactamase OXA-1 as an acyl complex with the carbapenem doripenem was determined to 1.4 A resolution. Unlike most class A and class C carbapenem complexes, the acyl carbonyl oxygen in the OXA-1-doripenem complex is bound in the oxyanion hole. Interestingly, no water molecules were observed in the vicinity of the acyl linkage, providing an explanation for why carbapenems inhibit OXA-1. The side chain amine of K70 remains fully carboxylated in the acyl structure, and the resulting carbamate group forms a hydrogen bond to the alcohol of the 6alpha-hydroxyethyl moiety of doripenem. The carboxylate attached to the beta-lactam ring of doripenem is stabilized by a salt bridge to K212 and a hydrogen bond with T213, in lieu of the interaction with an arginine side chain found in most other beta-lactamase-beta-lactam complexes (e.g., R244 in the class A member TEM-1). This novel set of interactions with the carboxylate results in a major shift of the carbapenem's pyrroline ring compared to the structure of the same ring in meropenem bound to OXA-13. Additionally, bond angles of the pyrroline ring suggest that after acylation, doripenem adopts the Delta(1) tautomer. These findings provide important insights into the role that carbapenems may have in the inactivation process of class D beta-lactamases.
碳青霉烯类抗生素的临床疗效取决于其对β-内酰胺酶水解作用的抗性。通过将结构为 D 类β-内酰胺酶 OXA-1 的酰基复合物与碳青霉烯类药物多利培南确定为 1.4A 分辨率。与大多数 A 类和 C 类碳青霉烯类复合物不同,OXA-1-多利培南复合物中的酰基羰基氧结合在氧阴离子穴中。有趣的是,在酰基键附近没有观察到水分子,这为为什么碳青霉烯类药物抑制 OXA-1 提供了一个解释。侧链氨基的 K70 在酰基结构中仍然完全羧化,生成的氨基甲酸盐基团与多利培南的 6α-羟乙基部分的醇形成氢键。与大多数其他β-内酰胺酶-β-内酰胺复合物(例如,A 类成员 TEM-1 中的 R244)中发现的相互作用不同,多利培南β-内酰胺环上的羧酸酯通过盐桥与 K212 稳定,并与 T213 形成氢键。这种与羧酸酯的新的相互作用导致与 OXA-13 结合的美罗培南结合的相同环的吡咯烷环发生重大位移。此外,吡咯烷环的键角表明,酰化后,多利培南采用 Delta(1)互变异构体。这些发现为碳青霉烯类药物在 D 类β-内酰胺酶失活过程中可能发挥的作用提供了重要的见解。